Over two million people in the US who have survived stroke continue to struggle with everyday communication because of residual language difficulties, or aphasia. Language therapy is often effective in aiding language recovery after stroke. However, many hours of language intervention are required to demonstrate an effect, and most insurance providers do not cover an adequate number of treatment sessions.
In this project, we will investigate the effects of a selective serotonin reuptake inhibitor (SSRI), escitalopram, on augmenting language therapy’s effectiveness in individuals with aphasia within the first three months after stroke.
Please contact us to learn more!